NO301774B1 - cDNA kodende for en del av Rb-proteinet, fremgangsmåte for detektering av predisposisjon overfor utvikling av retinoblastom og diagnostisk in vitro analysesett - Google Patents

cDNA kodende for en del av Rb-proteinet, fremgangsmåte for detektering av predisposisjon overfor utvikling av retinoblastom og diagnostisk in vitro analysesett Download PDF

Info

Publication number
NO301774B1
NO301774B1 NO885712A NO885712A NO301774B1 NO 301774 B1 NO301774 B1 NO 301774B1 NO 885712 A NO885712 A NO 885712A NO 885712 A NO885712 A NO 885712A NO 301774 B1 NO301774 B1 NO 301774B1
Authority
NO
Norway
Prior art keywords
cdna
retinoblastoma
tumor
dna
gene
Prior art date
Application number
NO885712A
Other languages
English (en)
Norwegian (no)
Other versions
NO885712D0 (no
NO885712L (no
Inventor
Yuen-Kai T Fung
Ang Anne T
William F Benedict
A Linn Murphree
Original Assignee
Canji Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canji Inc filed Critical Canji Inc
Publication of NO885712D0 publication Critical patent/NO885712D0/no
Publication of NO885712L publication Critical patent/NO885712L/no
Publication of NO301774B1 publication Critical patent/NO301774B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Graft Or Block Polymers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
NO885712A 1987-05-29 1988-12-22 cDNA kodende for en del av Rb-proteinet, fremgangsmåte for detektering av predisposisjon overfor utvikling av retinoblastom og diagnostisk in vitro analysesett NO301774B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712646A GB8712646D0 (en) 1987-05-29 1987-05-29 Structural evidence
PCT/US1988/001809 WO1988009387A1 (en) 1987-05-29 1988-05-27 A method for detecting the predisposition to retinoblastoma and a method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe

Publications (3)

Publication Number Publication Date
NO885712D0 NO885712D0 (no) 1988-12-22
NO885712L NO885712L (no) 1988-12-22
NO301774B1 true NO301774B1 (no) 1997-12-08

Family

ID=10618110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885712A NO301774B1 (no) 1987-05-29 1988-12-22 cDNA kodende for en del av Rb-proteinet, fremgangsmåte for detektering av predisposisjon overfor utvikling av retinoblastom og diagnostisk in vitro analysesett

Country Status (18)

Country Link
EP (2) EP0293266A3 (pt)
JP (1) JPH04500751A (pt)
KR (1) KR960002560B1 (pt)
AT (1) ATE86673T1 (pt)
AU (2) AU1983188A (pt)
DE (1) DE3879208T2 (pt)
DK (1) DK675088A (pt)
ES (1) ES2054880T3 (pt)
FI (1) FI895364A0 (pt)
GB (1) GB8712646D0 (pt)
GR (1) GR3007474T3 (pt)
IE (1) IE62296B1 (pt)
IL (1) IL86542A (pt)
NO (1) NO301774B1 (pt)
NZ (1) NZ224822A (pt)
PT (1) PT87614B (pt)
WO (1) WO1988009387A1 (pt)
ZA (1) ZA883805B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma
US7223842B1 (en) 1986-08-11 2007-05-29 Massachusetts Eye And Ear Infirmary Detection of proteins whose absence is associated with a neoplasm
US5853988A (en) * 1986-08-11 1998-12-29 Massachusetts Eye And Ear Infirmary Diagnosis of retinoblastoma
US7384735B1 (en) 1986-08-11 2008-06-10 Massachusetts Eye And Ear Infirmary Retinoblastoma nucleic acids
EP0264274A3 (en) * 1986-10-14 1989-02-01 Canon Kabushiki Kaisha Optical recording medium
US5268267A (en) * 1987-08-21 1993-12-07 The General Hospital Corporation Method for diagnosing small cell carcinoma
JP3163090B2 (ja) * 1988-01-21 2001-05-08 マサチューセッツ アイ アンド イヤー インファーマリー 網膜芽腫診断剤
EP0390323B2 (en) * 1989-03-29 2012-08-08 Johns Hopkins University Detection of loss of the wild-type p53 gene
CA2060267A1 (en) * 1991-02-22 1992-08-23 Joe W. Gray Chromosome specific staining to detect genetic rearrangements
EP0667918B1 (en) * 1991-11-14 2000-02-16 Digene Diagnostics, Inc. Non-radioactive hybridization assay and kit
EP0675967A4 (en) * 1992-10-01 1999-04-28 Gen Hospital Corp Functional assay for tumor suppressor genes.
JPH06296489A (ja) * 1992-11-20 1994-10-25 Univ Texas Syst 網膜芽腫−関連タンパク質をコードする細胞性遺伝子
US5496731A (en) * 1993-03-25 1996-03-05 Xu; Hong-Ji Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy
US5969120A (en) * 1993-09-03 1999-10-19 Research Development Foundation Mutants of the RB and P53 genes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341576C (en) * 1986-08-11 2008-07-08 Thaddeus P. Dryja Diagnosis of retinoblastoma

Also Published As

Publication number Publication date
KR890701763A (ko) 1989-12-21
EP0293266A2 (en) 1988-11-30
FI895364A7 (fi) 1989-11-10
ZA883805B (en) 1990-11-28
IL86542A (en) 1994-02-27
EP0364490A4 (en) 1990-05-14
AU1983188A (en) 1988-12-21
DK675088D0 (da) 1988-12-02
DE3879208T2 (de) 1993-07-22
DE3879208D1 (de) 1993-04-15
KR960002560B1 (ko) 1996-02-22
GB8712646D0 (en) 1987-07-01
AU657143B2 (en) 1995-03-02
EP0364490A1 (en) 1990-04-25
ES2054880T3 (es) 1994-08-16
IE881613L (en) 1988-11-29
IE62296B1 (en) 1995-01-25
PT87614B (pt) 1993-03-31
NO885712D0 (no) 1988-12-22
DK675088A (da) 1988-12-02
AU2038292A (en) 1992-09-24
FI895364A0 (fi) 1989-11-10
EP0364490B1 (en) 1993-03-10
EP0293266A3 (en) 1990-04-11
ATE86673T1 (de) 1993-03-15
NO885712L (no) 1988-12-22
IL86542A0 (en) 1988-11-15
JPH04500751A (ja) 1992-02-13
GR3007474T3 (pt) 1993-07-30
WO1988009387A1 (en) 1988-12-01
PT87614A (pt) 1988-06-01
NZ224822A (en) 1989-12-21

Similar Documents

Publication Publication Date Title
Henson et al. The retinoblastoma gene is involved in malignant progression of astrocytomas
German Consortium for Hereditary Breast and Ovarian Cancer Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population
Gayther et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation
Valero et al. A highly sensitive genetic protocol to detect NF1 mutations
Wimmer et al. Spectrum of single‐and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients
Gessler et al. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors
Okawa et al. Expression and sequence analysis of candidates for the 1p36. 31 tumor suppressor gene deleted in neuroblastomas
Albrecht et al. Spectrum of gross deletions and insertions in the RB1 gene in patients with retinoblastoma and association with phenotypic expression
Pollock et al. PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines
Laud et al. Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
Evans et al. Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction
Pulkkinen et al. Detection of sequence variants in the gene encoding the β3 chain of laminin 5 (LAMB3)
EP0364490B1 (en) A method for detecting a retinoblastoma gene defect in tumors using a retinoblastoma gene probe
US20120207755A1 (en) Cancer
Lo et al. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset)
Loftus et al. A custom capture sequence approach for oculocutaneous albinism identifies structural variant alleles at the OCA2 locus
Yin et al. Identification of a region of homozygous deletion on 8p22–23.1 in medulloblastoma
WO1995018818A1 (en) Polymorphism at codon 36 of the p53 gene
JP2014532403A (ja) ゲノムモールスコードを分子コーミングと併用する乳癌及び卵巣癌遺伝子並びに遺伝子座ｂｒｃａ１及びｂｒｃａ２におけるゲノム再編成の検出、可視化、及び高解像度物理マッピングの方法
Chen et al. Defining a common region of deletion at 13q21 in human cancers
Zahn et al. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis
Vater et al. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma
Lerebours et al. Evidence of chromosome regions and gene involvement in inflammatory breast cancer
JP5227167B2 (ja) Ｃｈｒ８ｑ２４．２１での変異体は癌のリスクを与える
Skolnick et al. Genetic predisposition to melanoma